Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
investing
3
×
life sciences
national blog main
san francisco blog main
3
×
san francisco top stories
startups
boston top stories
clinical trials
deals
fda
national top stories
san francisco
alphabet
ame cloud ventures
american diabetes association
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
boulder/denver blog main
boulder/denver top stories
brexanolone
broad institute of harvard and mit
brook byers
camp4 therapeutics
cancer
cancer immunotherapy
charles chu
clostridium difficile
colleen cutcliffe
computational biology
crispr
crispr cas14
crispr therapeutics
crispr-cas9
decheng capital
denali therapeutics
detroit blog main
What
today
3
×
available
ahead
ambien
american
annual
asco
attendees
attention
balance
based
big
bio
biome
biosciences
biotech
blood
camp’s
cancer
cas
cash
cheaper
chicago
city
clinical
combinations
community’s
crispr
days
develop
diabetes
diagnostics
drug
expanding
expects
eyes
faster
focus
food
healthy
Language
unset
Current search:
investing
×
today
×
" san francisco blog main "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More